Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-02-03

Clinical Trial Update: PRISMA-PET - Primary Staging of Prostate Cancer With PSMA [NA]

View source ↗

Summary

The PRISMA-PET trial for primary staging of prostate cancer using PSMA imaging has been terminated. Sponsor Odense University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Odense University Hospital | Conditions: Prostate Cancer | NA | Status: TERMINATED